THOMAS JEFFERSON UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1824-01-01

Employees: 10K

Market Cap: -

Website: http://www.jefferson.edu

Clinical Trials

Timing Impact of Early vs. Late Cranioplasty on Hemicraniectomy Outcomes

Not Applicable

Active, not recruiting

Conditions: Craniocerebral Trauma
Stroke
Intracranial Hemorrhages

Interventions: Procedure: Early cranioplasty
Procedure: Standard-of-care cranioplasty

First Posted Date: 2024-10-09

Last Posted Date: 2024-10-09

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 44

Registration Number: NCT06632587

Locations: 🇺🇸
Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania, United States

Tebentafusp-tebn With LDT in Metastatic UM

Phase 1

Not yet recruiting

Conditions: Metastatic Uveal Melanoma

Interventions: Drug: Tebentafusp-Tebn
Drug: GM-CSF (Sargramostim)
Drug: BCNU

First Posted Date: 2024-10-04

Last Posted Date: 2025-02-10

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 109

Registration Number: NCT06626516

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

SHAPE for ICP Assessment

Phase 2

Recruiting

Conditions: Lumbar Puncture

Interventions: Drug: Perflutren lipid microsphere

First Posted Date: 2024-08-26

Last Posted Date: 2025-04-22

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 20

Registration Number: NCT06571786

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Analgesic Techniques for Rib Fractures

Phase 4

Recruiting

Conditions: Rib Fractures

Interventions: Drug: Lidocaine bolus (1 mg/kg) and infusion starting at 1 mg/kg/h
Procedure: ESP block with catheter using ropivacaine (bolus followed by continuous infusion)

First Posted Date: 2024-07-25

Last Posted Date: 2024-10-24

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 24

Registration Number: NCT06519929

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

MBC Physical Activity Study

Not Applicable

Recruiting

Conditions: Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Breast Carcinoma

Interventions: Other: Exercise Intervention
Other: Health Promotion and Education
Other: Internet-Based Intervention
Other: Physical Activity
Other: Questionnaire Administration

First Posted Date: 2024-07-15

Last Posted Date: 2025-04-25

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 50

Registration Number: NCT06500858

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Developing a Nutrition Support Assessment Tool

Not Applicable

Active, not recruiting

Conditions: Nutrition Assessment
Food Insecurity

Interventions: Other: Nutrition Interventions

First Posted Date: 2024-06-10

Last Posted Date: 2025-04-02

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 200

Registration Number: NCT06450860

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Resolution of Pudendal Neuralgia in Chronic Pelvic Pain Using a Novel Biologic Therapy

Active, not recruiting

Conditions: Chronic Pelvic Pain Syndrome

First Posted Date: 2024-05-22

Last Posted Date: 2024-05-22

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 50

Registration Number: NCT06425575

Locations: 🇺🇸
Thomas Jefferwson University Hospital, Philadelphia, Pennsylvania, United States

Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)

Not Applicable

Recruiting

Conditions: Gestational Diabetes
Pregnancy Related

Interventions: Drug: Insulin

First Posted Date: 2024-05-17

Last Posted Date: 2024-11-22

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 430

Registration Number: NCT06419803

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes

Not Applicable

Recruiting

Conditions: Gestational Diabetes
Pregnancy Related

Interventions: Drug: Insulin

First Posted Date: 2024-05-17

Last Posted Date: 2024-11-21

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 430

Registration Number: NCT06419777

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Neoadjuvant Tebentafusp for Uveal Melanoma

Phase 2

Not yet recruiting

Conditions: Locally Advanced Unresectable Uveal Melanoma

Interventions: Drug: Tebentafusp-Tebn

First Posted Date: 2024-05-16

Last Posted Date: 2025-02-10

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 19

Registration Number: NCT06414590

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Home Terms & Conditions Privacy Policy